Xbira (Abiraterone Acetate) is an oral medication used in the treatment of prostate cancer. It works by inhibiting the production of androgens, which can fuel the growth of prostate cancer cells. This medication is typically prescribed for patients with advanced prostate cancer who are not responding to other treatments.
Xbira targets the enzyme CYP17, which plays a crucial role in the production of testosterone and other androgens. By blocking this enzyme, Xbira lowers androgen levels, thereby slowing the progression of cancer.
The typical dosage of Xbira is one tablet taken once daily, on an empty stomach. It is essential to follow the prescribed dosage and administration guidelines provided by your healthcare professional.
Before starting treatment with Xbira, inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking. Regular monitoring of liver function and blood pressure is recommended during treatment.
Store Xbira in a cool, dry place away from direct sunlight and out of reach of children. Do not use the medication after the expiration date.
Xbira (Abiraterone Acetate) is a vital option for patients dealing with advanced prostate cancer, offering a targeted approach to treatment. Always consult with your healthcare provider for personalized advice and to ensure the best outcomes during your treatment journey.